IHH Singapore goes preventive with new Healthspan programme

It estimates biological age relative to a person’s chronological age by blood analysis.

IHH Healthcare Singapore (IHH SG) has launched Healthspan, a preventive health and longevity programme, unveiled at FutureHealth.Now 2026, the flagship event of parent company IHH Healthcare.

The centrepiece offering is AgeQ, a clinical assessment that analyses seven blood biomarkers to estimate biological age relative to a person’s chronological age.

The score is benchmarked against a database of over 300,000 individuals.

Additionally, Healthspan connects patients into IHH SG's existing network, comprising four private hospitals, more than 50 clinics and over 1,500 specialists.

The programme is structured around a four-part framework called LIFT—Learn, Interpret, Finetune and Track.

Individuals can choose from five screening tiers: AgeQ, Vitals, Foundations, Explorer and Pioneer, each offering different levels of diagnostic depth and clinical engagement.

The programme also draws on specialised services from the Mount Elizabeth Novena Centre for Genomic Health, under IHH's established brands Gleneagles, Mount Elizabeth and Parkway.

Beyond the initial blood test, Healthspan will integrate six core capabilities including baseline health profiling, proactive risk identification, personalised care pathways, multidisciplinary specialist coordination, precision lifestyle optimisation, and continuous monitoring with real-time intervention adjustments.

Peter Chow, CEO of IHH Healthcare Singapore, said the initiative shifts care upstream from reactive treatment to proactive, predictive and personalised health management, aiming to extend not just lifespan but healthspan, the number of years lived free of illness and disability.